PARP1 and neoplasm: The CRISPR/Cas9-containing exosomes could suppress the expression of poly (ADP-ribose) polymerase-1 (PARP-1) to induce the tumor apoptosis and enhance the chemosensitivity of tumor cells to cisplatin.